CAMP

CAMP4 Therapeutics Corporation - Common Stock (CAMP)

About CAMP4 Therapeutics Corporation - Common Stock (CAMP)

CAMP4 Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a class of RNA-targeting therapeutics for upregulating gene expression and restoration of healthy protein levels to treat a broad range of genetic diseases. Its lead product candidate is CMP-002. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Details

Daily high

$4.48

Daily low

$4.18

Price at open

$4.26

52 Week High

$7.75

52 Week Low

$2.20

Market cap

266.7M

Dividend yield

Volume

105,455

Avg. volume

295,598

P/E ratio

-1.91

CAMP4 Therapeutics Corporation - Common Stock News